Registration Dossier

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: study with limited documentation

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1973
Report date:
1973

Materials and methods

Principles of method if other than guideline:
Acute dermal toxicity test in rabbits
GLP compliance:
no
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
(2S-cis)-tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran
EC Number:
221-217-9
EC Name:
(2S-cis)-tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran
Cas Number:
3033-23-6
Molecular formula:
C10H18O
IUPAC Name:
(2S-cis)-tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran
Details on test material:
- Name of test material (as cited in study report): Rose oxide levo
- Other: stereoisomer of rose oxide
- Lot/batch No.: 73-222
no further data given

Test animals

Species:
rabbit
Strain:
not specified
Sex:
not specified
Details on test animals or test system and environmental conditions:
no data

Administration / exposure

Type of coverage:
not specified
Vehicle:
not specified
Duration of exposure:
no data
Doses:
5000 mg/kg bw
No. of animals per sex per dose:
3 (sex not specified)
Control animals:
other: not applicable
Details on study design:
- Duration of observation period following administration: 14 days
no further data given

Results and discussion

Effect levels
Sex:
not specified
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortality observed
Clinical signs:
other: Slight erythema in 2/3 animals Moderate erythema in 1/3 animals Moderate edema in 3/3 animals
Gross pathology:
No data

Applicant's summary and conclusion